Avecho Biotechnology Limited

ASX:AVE 주식 보고서

시가총액: AU$6.3m

Avecho Biotechnology 미래 성장

Future 기준 확인 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Avecho Biotechnology.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Pharmaceuticals 수익 성장54.6%
매출 성장률n/a
향후 자기자본 수익률n/a
애널리스트 커버리지

None

마지막 업데이트n/a

최근 미래 성장 업데이트

업데이트 없음

Recent updates

Companies Like Avecho Biotechnology (ASX:AVE) Are In A Position To Invest In Growth

Jan 13
Companies Like Avecho Biotechnology (ASX:AVE) Are In A Position To Invest In Growth

Here's Why We're Watching Avecho Biotechnology's (ASX:AVE) Cash Burn Situation

May 31
Here's Why We're Watching Avecho Biotechnology's (ASX:AVE) Cash Burn Situation

Avecho Biotechnology (ASX:AVE) Is In A Good Position To Deliver On Growth Plans

Nov 04
Avecho Biotechnology (ASX:AVE) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Avecho Biotechnology (ASX:AVE) Will Use Its Cash Wisely

Jul 14
We're Hopeful That Avecho Biotechnology (ASX:AVE) Will Use Its Cash Wisely

We Think Avecho Biotechnology (ASX:AVE) Can Afford To Drive Business Growth

Mar 23
We Think Avecho Biotechnology (ASX:AVE) Can Afford To Drive Business Growth

We're Not Very Worried About Avecho Biotechnology's (ASX:AVE) Cash Burn Rate

Dec 08
We're Not Very Worried About Avecho Biotechnology's (ASX:AVE) Cash Burn Rate

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Avecho Biotechnology 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

ASX:AVE - 애널리스트의 미래 추정치 및 과거 재무 데이터 (AUD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
6/30/20240-3-3-3N/A
3/31/20240-3-3-3N/A
12/31/20230-3-3-3N/A
9/30/20231-4-3-3N/A
6/30/20231-4-2-2N/A
3/31/20231-3-2-2N/A
12/31/20221-2-2-2N/A
9/30/20221-2-2-2N/A
6/30/20221-2-2-1N/A
3/31/20221-3-2-2N/A
12/31/20211-3-3-3N/A
9/30/20211-3-3-3N/A
6/30/20210-3-2-2N/A
3/31/20210-3-2-2N/A
12/31/20200-3-1-1N/A
9/30/20200-2-2-2N/A
6/30/20200-2-2-2N/A
3/31/20202-1-1-1N/A
12/31/20194111N/A
9/30/20194111N/A
6/30/20195011N/A
3/31/20193-200N/A
12/31/20181-4-2-2N/A
6/30/20181-6-5-5N/A
3/31/20181-7N/A-6N/A
12/31/20171-9N/A-6N/A
6/30/20171-16N/A-6N/A
3/31/20171-17N/A-6N/A
12/31/20162-17N/A-6N/A
9/30/20162-17N/A-6N/A
6/30/20163-17N/A-6N/A
3/31/20162-18N/A-7N/A
12/31/20152-20N/A-9N/A
9/30/20152-17N/A-10N/A
6/30/20153-14N/A-11N/A
3/31/20152-10N/A-9N/A
12/31/20142-7N/A-7N/A
6/30/20141-7N/A-7N/A
3/31/20141-9N/A-8N/A
12/31/20131-11N/A-9N/A

애널리스트 미래 성장 예측

수입 대 저축률: Insufficient data to determine if AVE's forecast earnings growth is above the savings rate (2.4%).

수익 vs 시장: Insufficient data to determine if AVE's earnings are forecast to grow faster than the Australian market

고성장 수익: Insufficient data to determine if AVE's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: Insufficient data to determine if AVE's revenue is forecast to grow faster than the Australian market.

고성장 수익: Insufficient data to determine if AVE's revenue is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if AVE's Return on Equity is forecast to be high in 3 years time


성장 기업 발견